To investigate the key genetic alterations in KRAS-mutant NSCLC, we interrogated large publicly available datasets from the Broad Institute22, the Cancer Genome Atlas4 and the Memorial Sloan Kettering Cancer Center (MSKCC)23 using cBioPortal24,25. This evidence concerns the gene KRAS and non-small cell lung carcinoma.